J.B. Chemicals & Pharmaceuticals Ltd. Stock Forecast Period (n+6m) 30 Jun 2020


Stock Forecast


As of Tue Jun 30 2020 10:02:36 GMT+0000 (Coordinated Universal Time) shares of J.B. Chemicals & Pharmaceuticals Ltd. 0.4 percentage change in price since the previous day's close. Around 38168 of 80236640 changed hand on the market. The Stock opened at 703.9 with high and low of 701 and 709 respectively. The price/earnings ratio is: 21.59 and earning per share is 32.66. The stock quoted a 52 week high and low of 315.05 and 743.8 respectively.

BOSTON (AI Forecast Terminal) Tue, Jun 30, '20 AI Forecast today took the forecast actions: In the context of stock price realization of J.B. Chemicals & Pharmaceuticals Ltd. is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+6m) for J.B. Chemicals & Pharmaceuticals Ltd. as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of J.B. Chemicals & Pharmaceuticals Ltd. as below:

J.B. Chemicals & Pharmaceuticals Ltd. Credit Rating Overview


We rerate J.B. Chemicals & Pharmaceuticals Ltd. because business model transition. We use econometric methods for period (n+6m) simulate with RRS Wilcoxon Sign-Rank Test. Reference code is: 3824. Beta DRL value REG 33 Rational Demand Factor LD 4101.2118. When assessing strong or exceptional liquidity, we include all forecasted capital expenditures over the next 24 months, including discretionary growth capital spending. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for J.B. Chemicals & Pharmaceuticals Ltd. as below:
Frequently Asked QuestionsQ: What is J.B. Chemicals & Pharmaceuticals Ltd. stock symbol?
A: J.B. Chemicals & Pharmaceuticals Ltd. stock referred as NSE:JBCHEPHARM
Q: What is J.B. Chemicals & Pharmaceuticals Ltd. stock price?
A: On share of J.B. Chemicals & Pharmaceuticals Ltd. stock can currently be purchased for approximately 705.5
Q: Do analysts recommend investors buy shares of J.B. Chemicals & Pharmaceuticals Ltd. ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for J.B. Chemicals & Pharmaceuticals Ltd. at daily forecast section
Q: What is the earning per share of J.B. Chemicals & Pharmaceuticals Ltd. ?
A: The earning per share of J.B. Chemicals & Pharmaceuticals Ltd. is 32.66
Q: What is the market capitalization of J.B. Chemicals & Pharmaceuticals Ltd. ?
A: The market capitalization of J.B. Chemicals & Pharmaceuticals Ltd. is 54553429217
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. All data and information is provided “as is” for personal informational purposes only, and is not intended for trading purposes or advice. Please consult your broker or financial representative to verify pricing before executing any trade.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com